Smart Money Alert
Syngene International Limited
DecreasedQuarterly
SYNGENEHealthcare Research, Analytics & TechnologyMarket Cap₹16K Cr
Stake
2.13% → 1.16%
Holding
46.76 L shares
Change
−39.30 L shares
As of
Sept 2026
Since alert0.0%₹386.10 → ₹386.10
Nifty 500.0%
Government of Singapore
Foreign Investor
The move
The Government of Singapore reduced its stake in Syngene International from 2.13% to 1.16%, selling 39.3 lakh shares.
About Syngene International Limited
Visit stock India's first Contract Research Organization, Syngene provides integrated drug discovery, development, and manufacturing services through a single platform known as CRAMS. Established in 1993 as a Biocon subsidiary, the company operates extensive research and manufacturing facilities spanning multiple locations across the country. It serves global pharmaceutical and biotechnology clients with end-to-end solutions, from early-stage research through commercial-scale production.
About Government of Singapore
Visit investor Singapore sovereign investor (GIC), managing the Government of Singapore's foreign reserves. One of the world's largest SWFs with significant Indian equity holdings.
Get the next move the moment it happens.
Follow Government of Singapore and Syngene International Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
HSBC Mutual FundExited
HSBC Mutual Fund is no longer listed among the key shareholders of Syngene International Limited, having previously held 1.55 percent. This change indicates that HSBC Mutual Fund either completely exited the position or trimmed it below the 1 percent reporting threshold.
16 Oct 2026
Read more Mirae Asset Mutual FundDecreased
Mirae Asset Mutual Fund decreased its stake in Syngene International Limited from 1.85% to 1.05%, selling 31,95,263 shares.
16 Oct 2026
Read more Tata Mutual FundNew position
Tata Mutual Fund acquired a 1.02% stake in Syngene International Limited, holding 41,09,003 shares. Its holding rose to 1.02% from under 1% in the latest shareholding filing.
16 Oct 2026
Read more DSP Mutual FundIncreased
DSP Mutual Fund increased its stake in Syngene International from 4.61% to 4.71%, acquiring 4,26,177 shares. Based on the market price of ₹384.20, the transaction is valued at approximately ₹16.37 Cr.
16 Oct 2026
Read more Nippon India Mutual FundIncreased
Nippon India Mutual Fund increased its stake in Syngene International Limited from 7.73% to 8.00%. The fund house acquired 11,09,508 shares, raising its total holding to 3,22,95,397 shares.
16 Oct 2026
Read more Larsen & Toubro Limited
Direction, size, price and stake change for this move, with what it means for the company.
17 Oct 2026. Sign in to see this move
TVS Motor Company LimitedExited
Government of Singapore is no longer listed among TVS Motor Company Limited's major shareholders, meaning the investor either fully exited or trimmed its previous 1.01 percent stake below the 1 percent reporting threshold.
TVSMOTOR16 Oct 2026
Read more Max Healthcare Institute LimitedIncreased
Government of Singapore increased its stake in Max Healthcare Institute Limited from 4.28% to 4.35%, acquiring 65,99,857 shares.
MAXHEALTH16 Oct 2026
Read more Aditya Birla Fashion and Retail LimitedExited
Government of Singapore, last holding 3.29 percent, has dropped off Aditya Birla Fashion and Retail Limited's major shareholder list. The change signals either a complete exit or a reduction to under the 1 percent public disclosure threshold.
ABFRL16 Oct 2026
Read more Power Finance Corporation LimitedExited
Government of Singapore no longer features on the latest Power Finance Corporation Limited shareholder list, meaning the investor either exited entirely or pared its previous 1.25 percent stake below the 1 percent regulatory reporting threshold.
PFC16 Oct 2026
Read more